Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Bolder Biotechnology, Inc. - Product Pipeline Review - 2016 Summary
Global Markets Direct's, 'Bolder Biotechnology, Inc. - Product Pipeline Review - 2016', provides an overview of the Bolder Biotechnology, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Bolder Biotechnology, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Bolder Biotechnology, Inc. - The report provides overview of Bolder Biotechnology, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Bolder Biotechnology, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Bolder Biotechnology, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Bolder Biotechnology, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Bolder Biotechnology, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Bolder Biotechnology, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Bolder Biotechnology, Inc. Snapshot 5 Bolder Biotechnology, Inc. Overview 5 Key Information 5 Key Facts 5 Bolder Biotechnology, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Bolder Biotechnology, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Bolder Biotechnology, Inc. - Pipeline Products Glance 11 Bolder Biotechnology, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 Bolder Biotechnology, Inc. - Drug Profiles 13 BBT-007 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 BBT-009 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 BBT-015 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 BBT-018 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 BBT-021 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 BBT-031 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 BBT-032 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 BBT-046 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 BBT-059 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 BBT-012 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Bolder Biotechnology, Inc. - Pipeline Analysis 23 Bolder Biotechnology, Inc. - Pipeline Products by Target 23 Bolder Biotechnology, Inc. - Pipeline Products by Molecule Type 24 Bolder Biotechnology, Inc. - Pipeline Products by Mechanism of Action 25 Bolder Biotechnology, Inc. - Dormant Projects 26 Bolder Biotechnology, Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables
Bolder Biotechnology, Inc., Key Information 5 Bolder Biotechnology, Inc., Key Facts 5 Bolder Biotechnology, Inc. - Pipeline by Indication, 2016 8 Bolder Biotechnology, Inc. - Pipeline by Stage of Development, 2016 9 Bolder Biotechnology, Inc. - Monotherapy Products in Pipeline, 2016 10 Bolder Biotechnology, Inc. - Preclinical, 2016 11 Bolder Biotechnology, Inc. - Discovery, 2016 12 Bolder Biotechnology, Inc. - Pipeline by Target, 2016 23 Bolder Biotechnology, Inc. - Pipeline by Molecule Type, 2016 24 Bolder Biotechnology, Inc. - Pipeline Products by Mechanism of Action, 2016 25 Bolder Biotechnology, Inc. - Dormant Developmental Projects,2016 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.